Vitamin K deficiency rates rise as parents increasingly refuse newborn shots
A nationwide study found that rates of vitamin K deficiency and bleeding are multiplying as mistrust in public health professionals grows.

Rates of vitamin K deficiency (VKD) and vitamin K–deficient bleeding (VKDB) are multiplying in the United States. Researchers analyzed records from more than 11 million infants aged 0 to 6 months born at 35 weeks' gestation or later who received care between 2017 and 2025.
The study, led by Elizabeth Wolf, M.D., MPH, a pediatrician at Children's Hospital of Richmond at VCU, found that the proportion of newborns not receiving intramuscular vitamin K rose from 2.9% between 2017 and 2024 to 5.2%.
Vitamin K is necessary for the activation of specialized proteins for normal blood clotting. Newborns often have a deficiency because of poor gastrointestinal absorption, low vitamin K content in breast milk, and inefficient transfer from the placenta.
Classical VKD occurs between two days and one week after birth and leads to bruising and bleeding of the umbilicus. Late VKD, occurring between 1 week and 6 months of age, carries a 30% to 60% risk of intracranial hemorrhage, which can result in death, permanent brain damage, or seizures.
Researchers noted that refusal of vitamin K has risen as mistrust in public health professionals and doctors has grown. Like childhood vaccines, vitamin K has been a victim of its own success, as many parents are unaware that refusal can lead to serious lifelong consequences.
While the simultaneous decrease in injections and increase in diagnoses does not prove causality, Wolf noted that other explanations are unlikely because behaviors and diseases that increase VKD risk remained constant or decreased during this period.
Key facts
- The proportion of newborns not receiving intramuscular vitamin K rose from 2.9% to 5.2% between 2017 and 2024.
- Late vitamin K deficiency carries a 30% to 60% risk of intracranial hemorrhage.
- Researchers analyzed records from more than 11 million infants born at 35 weeks' gestation or later between 2017 and 2025.
Three perspectives
Neutral
Researchers analyzed electronic health record information from more than 11 million infants across the U.S. to study trends in vitamin K deficiency.
Positive
Researchers are seeking to better understand why parents refuse the medication to improve the uptake of this important treatment.
Negative
Increasing refusal of vitamin K injections is linked to rising rates of vitamin K deficiency and vitamin K–deficient bleeding.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.